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To analyse the efficacy of video-assisted thoracoscopy (VAT) in patients with spontaneous pneu-
mothorax (SP) and to identify clinical factors associated with outcome after VAT, one hundred and
one VATs were performed in 97 patients in this prospective study. Based on thoracoscopic appear-
ance of the visceral pleura three groups were identified, group (n 23) showing no abnormalities
treated with talcage, group 2 (n 23) showing bullae less than 2 cm treated with talcage and coag-
ulation, and group 3 (n 51) showing bullae larger than 2 cm treated with bullectomy by staplers,
coagulation and pleural scarification. Data were analyzed with regard to clinical factors such as age,
smoking behavior, pulmonary function and recurrent pneumothorax at presentation. No periopera-
tive deaths occurred. Overall relapse rate was 4.0% during a follow-up period of 3 to 38 months (me-
dian 27.2). Univariate analysis did not show any association of clinical factors with postoperative
complications (n 19). Patients with extensive pulmonary lesions had longer drainage and hospi-
talization time, probably due to insufficient sealing effects of stapler devices and/or pleural scarifi-
cation. Using multivariate analysis, none ofthe clinical factors had any association with complication
rate, drainage/hospitalization time or relapses after VAT. Only patients with bullae larger than 2 cm
treated with bullectomy by stapler devices were associated with longer drainage and hospitalization
time. This study suggests that VAT is effective in the treatment of spontaneous pneumothorax, al-
though the use of stapler devices and/or pleural scarification was associated with longer drainage and
hospitalization time, however, none of the clinical factors were associated with the outcome after
VAT.
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INTRODUCTION
Recurrence ofa primary spontaneous pneumothorax (SP)
is generally considered to be an indication for surgical
treatment.-3 The main purpose of surgery is to achieve
effective pleurodesis and to treat causal pulmonary le-
sions. In the past, chemical pleurodesis was performed by
tube thoracostomy or thoracoscopy; bullectomy and
pleurectomy by thoracotomy. Recently, video-assisted
thoracoscopy (VAT) made bullectomy possible by means
of less invasive procedures due to improved endoscopic
instrumentation andvideo imaging techniques.4-0 Pleural
symphysis can be achieved chemically using tetracycline,
doxycycline or talc,8,.2 mechanically by pleural abra-
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sion,3,4 thermally using electrocoagulation/Nd-YAG
laser,5,5 or surgically by stripping the apical part of the
parietal pleura with artery grasping forceps.7,1,6 Relapse
rates of bullectomy with endoscopic stapler devices vary
from 0 to 13%.3,17,22
The aims of this prospective study are: 1) to analyse the
efficacy of VAT in patients with spontaneous pneumoth-
orax and 2) to identify clinical factors associated with out-
come after VAT.
MATERIALS AND METHODS
Patients
From December 1991 to December 1994, 101 VATs were
performed in 97 patients with SP. There were 74 male and
23 female patients, mean age 33.1 years, ranging from 16
to 83 years. All patients had a negative history of chronic2 F.M.N.H. SCHRAMEL et al.
obstructive pulmonary disease (COPD) at the time ofpre-
sentation. The characteristics of the patients are given in
Table 1.
Technique
All patients underwent VAT under general anesthesia,
with double lumen intubation in the standard thoracotomy
position. Initial trocar placement was in the fifth or sixth
intercostal space inwhich the thoracoscope is inserted into
the pleural cavity. A second smaller trocar is inserted in
the second intercostal space in the midclavicular line for
insertion ofthe grasping forceps. Complete collapse ofthe
lung was obtained in all cases. The visceral pleura was
judged as being normal or showing blebs and/or bullae.
The respective treatments were: group 1, insufflation
with 3 grams talc ifthe visceral pleura was normal. Group
2, coagulationby electrocautery ifblebs orbullae less than
2 cm were seen, followed by talc poudrage. Group 3, sta-
pling with Autosuture Multifire EndoGIA(R) 3.5, intro-
duced through a third trocar in the third or fourth
intercostal space in the posterior axillary line for bullae
larger than 2 cm. In this last group the parietal pleura was
also scarified using electrocoagulation at the level of the
first to the fifth costae.
A chest tube (charierre 20) was inserted under video-
thoracoscopic guidance through the fifth or sixth inter-
costal space in the midclavicular line on the ventral side
of the pleural cavity. Vacuum drainage was performed
until air leakage ceased and the lung had completely re-
expanded. The chest tube was removed if the lung re-
mained expanded one day after clamping.
Drainage time (DT) of more than four days was con-
sidered prolonged. Total days of admission (hospitaliza-
tion time (HT)) after VAT was considered prolonged if
this exceeded five days.
Six weeks afterVAT, apulmonary function testwas per-
formed by spirometry. Forced expiratory volume in one
second and vital capacity were measured using a pneu-
motachometer(Jaeger, Mastedab). Normal predictive val-
ues were taken from Quanjer et al. 8
Table 1 Patient characteristics
Group Group 2 Group 3 Total
n 23 n 23 n 51 n 97
Mean age+/-SD 26.1 +/- 5.6 28.3_+9.9 38.5 +/- 15.7 33.1 +/- 13.8
Smokers 17 17 33 67
Obstructive PF* 3 2 7 12
Recurrent SP 8 7 11 26
Abbreviations: n: number, SD: standard deviation, PF: pulmonary function, SP:
spontaneous pneumothorax.
*: Pulmonary function tests of 15 patients were not available.
Statistics
Univariate analysis: the unpaired test was used to assess
differences of the various patient characteristics and for
comparingDT andHT in different subgroups. Chi-square
test was used for comparing the complication rate in dif-
ferent subgroups.
Multivariate analysis (logistic regression) was used to
determine the significant association of several clinical
factors (age, smoking behavior, pulmonary function, re-
current SP, endoscopic appearance) and ultimate result
(complication rate, drainage time, hospitalization time, re-
lapse) after VAT. A p value of< 0.05 was considered sta-
tistically significant.
RESULTS
Patient and Treatment Data
One hundred and one VATs were performed in 97 patients
for SP. Patient characteristics are described in Table 1.
Four patients underwent VAT twice, due to contralateral
pneumothorax. In three patients of group 3, a submam-
marian incision was needed to remove large bullous de-
generated lung tissue.
Data were analyzed in regard to clinical factors such as
age, smoking behavior, pulmonary function, first or re-
current pneumothorax at presentation and thoracoscopic
appearance. No significant differences in smoking be-
havior, pulmonary function, first or recurrent SP at pre-
sentation between the three groups was found. Patients in
group 3 were significantly older (p < 0.001) even if pa-
tients with a obstructive pulmonary function were ex-
cluded from analysis. There was no significant difference
in the three groups regarding treatment indications for first
or recurrent pneumothoraces. Followup ranged from 3 to
38 months (median 27.2).
Complications
No complications during the 101 VAT procedures and no
perioperative deaths occurred. Nineteen patients (19%)
had minor postoperative complications, fifteen ofthem of
pulmonary origin (Table 2). Invasive interventions were
not required except the insertion ofnew chest tubes in five
patients. Conversion to open thoracotomy was not neces-
sary. Four patients had relapse of the pneumothorax
(4.0%), all from group 3. The relapse rate in this group
was 7.7%, occurring within the first two years (ranging
from 1.7 to 22.5 months, median 3.3).
The complication rates among the three groups were
not significantly different, also when several clinical fac-
tors were analyzed separately (Table 3).PROGNOSTIC FACTORS WITH SPONTANEOUS PNEUMOTHORAX 3
Drainage and Hospitalization Time
DT and HT are given in Table 4. Significantly shorter
drainage and hospitalization times were seen in patients
of group 2, patients without or with bullae smaller than 2
cm and patients with an uncomplicated postoperative
Table 2 Postoperative complications
n
Relapse 4
Redrainage 5
Atelectasis 2
Pneumonia 2
Reexpansion edema 2
Other 4
Total 19
Abbreviation: n: number.
Table 3 Postoperative complications and clinical factors
No complications Complications
n=82 n= 19 p
Mean age +_ SD 32.5 _+ 13.5 33.9 _
14.9 0.68
Age > 50 years 10 4 0.252
Group 1/2/3 21/21/40 4/4/11 0.742
Smoking 58 13 0.842
Obstructive PF* 8 4 0.192
Recurrent SP 20 7 0.272
Abbreviations: n: number, p: significance, SD: standard deviation, >: larger than,
PF: pulmonary function, SP: spontaneous pneumothorax.
*: Pulmonary function tests of 15 patients not available.
: Unpaired test, 2: Chi-square test.
course. Patients with obstructive pulmonary function had
a shorter DT but a longer HT. Non-smokers and patients
treated with coagulation showed a tendency toward a
shorter DT. Patients presenting with a first pneumothorax
had a shorter HT.
Multivariate analysis
Multivariate analysis (logistic regression) of the clinical
factors (age, smoking behavior, pulmonary function, re-
current pneumothorax at presentation) showed that only
the thoracoscopic demonstration of bullae larger than 2
cm was significantly associated with a prolonged DT and
HT. Other clinical factors were not associated with post-
operative complications, prolonged drainage/hospitaliza-
tion time or relapses.
DISCUSSION
There is no consensus regarding the best management of
SP. Treatment is aimed at preventing relapses. Surgery
provides the lowest relapse rates, varying from 0% to
3.6%.20.zl However, treatment morbidity is high, in con-
trast to tube thoracostomy, with a relapse rate up to 57%.20
VAT has proven its efficacy, with low relapse rates vary-
ing from 0 to 13% and low morbidity comparing to con-
ventional thoracotomy.3,7
In our series of 97 patients 101 VATs were successful
with low morbidity, no mortality and arelapse rate of4.0%
at a median follow-up of more than two years. Unlike the
Table 4 Mean drainage and hospitalization time (days)
DT +_SD pt HT SD
Group 4.6 _+ 2.8 < 0.001 6.0 _+ 2.8 0.003
Group 2 3.3 _+ 0.5 5.0 +_ 0.9
Group 3 4.9 +_ 3.0 6.9 4.3
Age < 50 years 4.5 2.7 0.11 6.0 _+ 2.7 0.05
Age > 50 years 4.0 1.5 7.1 +_ 6.5
Non-smokers 3.9 _+ 1.8 0.08 6.3 +_ 4.7 0.30
Smokers 4.6 2.8 6.1 +_ 2.8
Normal PF* 4.8 +_ 2.9 0.01 6.1 2.9 0.05
Obstructive PF* 3.5 0.7 7.7 _+_ 6.9
First SP 4.3 _+ 2.4 0.10 5.9 _+ 2.5 0.004
Recurrent SP 4.8 3.0 7.1 5.3
No bullae/bullae < 2 cm 3.9 _+ 2.0 0.02 5.9 _+ 2.1 0.005
Bullae > 2 cm 4.9 _+ 3.0 7.0 _+ 4.3
Complication 4.1 _
2.3 0.01 5.6 +_ 2.4 0.001
Complication + 5.6 _+ 3.3 8.5 5.9
Coagulation 4.6 _+ 2.7 0.08 6. +_ 2.7 0.51
Coagulation + 4.0 2.3 6.3 4.5
Total 4.4 _+ 2.6 6.2 3.5
Abbreviations: DT: drainage time, HT: hospitalization time, SD: standard deviation, p: significance, >: larger than, < less
than, PF: pulmonary function, SP: spontaneous pneumothorax.
*: Pulmonary function tests in 15 patients were not available.
Unpaired test.4 F.M.N.H. SCHRAMEL et al.
Table 5 Significance (pl) of association between clinical factors and
outcome after VAT, using logistic regression analysis.
Complications DT HT Relapse
Age 0.47 0.25 0.13 0.57
Smoking 0.85 0.28 0.70 0.96
Obstructive PF* 0.31 0.24 0.53 0.81
Recurrent SP 0.25 0.44 0.93 0.59
Builae > 2 cm 0.30 0.005 0.01 0.87
Abbrevations: DT: drainage time, HT: hospitalization time, p: significance, SP:
spontaneous pneumothorax, PF: pulmonary function, >: larger than.
*: Pulmonary function tests in 15 patients were not available.
i: Logistic regression analysis.
classification of Vanderscheuren, we distinguished only
three groups. 19None ofthe patients withoutpulmonary le-
sions showed adhesions. In the group with bullae larger
than 2 cm the relapse rate was 7.7%. This rate is compa-
rable with previous publications.3,22 Nineteen patients had
minor postoperative complications, ofwhich79% were of
pulmonary origin. Using univariate analysis we did not
find a clinical factor associated with a complicated post-
operative course. Even factors such as smoking, age and
pulmonary function, which presumably are risk factors for
acomplicatedcourse after surgery,:3were not significantly
related to postoperative complication. This was probably
due to less postoperative pain and rapid mobilization after
VAT.
Analyzing the patients characteristics,we demonstrated
that patients with extensive pulmonary lesions were sig-
nificantl older. The relation between age and parenchy-
mal changes is not surprising as it is known that bullae
grow with age.24 Assuming that all parenchymal abnor-
malities were adequately treated, the prolonged drainage
time in patients with large bullae might not be due to the
bullae themselves but to an insufficient sealing effect of
the staplers or inadequate pleurodesis by pleural scarifi-
cation. This is supported by the fact that patients treated
with coagulation had shorter drainage times. The addi-
tional sealing effect ofelectrocautery has been previously
described. 15
It was also surprising that patients with obstructive pul-
monary disease had shorter drainage times. However,
these patients were equally divided among the three
groups. Thus the presence of bullae was not correlated
with obstructive pulmonary function testing in patients
with spontaneous pneumothorax. This explains why these
patients did not show prolonged drainage time.
Using multivariate analysis age, smoking behavior, pul-
monary function and recurrent pneumothorax at presen-
tation were not associatedwith clinical outcome afterVAT.
Only the presence of large bullae had effect on drainage
and hospitalization time, probably related to the treatment
modality.
Figure I Endoscopic findings in a patient of group 3.
Figure 2 Cosmetic result afterVAT in a 19-year-old female patient.PROGNOSTIC FACTORS WITH SPONTANEOUS PNEUMOTHORAX 5
In conclusion, VAT is an effective technique to treat
spontaneous pneumothorax, although the usage of stapler
devices and/or pleural scarification was associated with
longer drainage and hospitalization time. There are no
clinical factors such as age, smoking behavior, pulmonary
function or presentation with recurrent pneumothorax
which are associated with the outcome after VAT.
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